AUSCANN GROUP HOLDINGS

auscann-group-holdings-logo

ENSURING 'GOOD MANUFACTURING PRACTICES', THEY ARE COMMITTED TO SUPPLYING THEIR CLIENTS WITH A CONSISTENT & RELIABLE SOURCE OF HIGH-QUALITY MEDICINAL CANNABIS. AUSCANN BRINGS TOGETHER A STRONG TEAM WITH RELEVANT & COMPLEMENTARY SKILL-SETS, EXPERIENCE AND NETWORKS.

#SimilarOrganizations #People #Financial #Website #More

AUSCANN GROUP HOLDINGS

Social Links:

Industry:
Alternative Medicine Cannabis

Founded:
1986-01-01

Address:
Australia, Isabela, Philippines

Country:
Philippines

Website Url:
http://www.auscann.com.au

Total Employee:
1+

Status:
Active

Total Funding:
33.4 M AUD


Similar Organizations

aphria-logo

Aphria

Aphria is a Canada-based company committed to providing accessible medical cannabis.

chalice-brands-logo

Chalice Brands

Chalice Brands is a fast growing company and leading cannabis oil solutions company built around recognized brands.

grassroots-cannabis-logo

Grassroots Cannabis

Grassroots Cannabis is a grower, processor, and dispenser, of medical cannabis in over four states including Maryland.

homology-medicines-logo

Homology Medicines

Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.

livwell-logo

LivWell

LivWell is dispensary company that provides exceptional cannabis products.

red-white-bloom-rwb-logo

Red White & Bloom (RWB)

Red White & Bloom is the torchbearer leading a new frontier and setting a standard in the American cannabis industry.


Current Advisors List

not_available_image

Alex Wodak Am Medical Advisory Board @ AusCann Group Holdings
Advisor

Current Employees Featured

harry-karelis_image

Harry Karelis
Harry Karelis Executive Director @ AusCann Group Holdings
Executive Director

not_available_image

Layton Mills
Layton Mills Founder & Chief Executive Officer @ AusCann Group Holdings
Founder & Chief Executive Officer
2021-03-01

mal-washer_image

Mal Washer
Mal Washer Chairman @ AusCann Group Holdings
Chairman

Founder


not_available_image

Layton Mills

Stock Details


Company's stock symbol is ASX:AC8

Acquisitions List

Date Company Article Price
2020-11-16 Cannpal Animal Therapeutics Cannpal Animal Therapeutics acquired by AusCann Group Holdings 17.5 M USD

Official Site Inspections

http://www.auscann.com.au

  • Host name: ec2-3-106-151-219.ap-southeast-2.compute.amazonaws.com
  • IP address: 3.106.151.219
  • Location: Sydney Australia
  • Latitude: -33.8591
  • Longitude: 151.2002
  • Timezone: Australia/Sydney
  • Postal: 2000

Loading ...

More informations about "AusCann Group Holdings"

About us - AusCann

Contact; For more information please contact us Email: [email protected] Tel: 08 6444 1720 Postal Address: PO Box 1976 West Perth WA 6872 Submit online enquirySee details»

Who We Are - AusCann

CannPal Animal Therapeutics, a subsidiary of AusCann Group Holdings, is a global leader in the development of innovative, cannabinoid-derived therapeutic products to provide veterinarians โ€ฆSee details»

Org Chart AusCann Group - The Official Board

The organizational chart of AusCann Group displays its 5 main executives including Layton Mills. Toggle navigation The Official Board. ... AusCann Group www.auscann.com.au +61 881 335 โ€ฆSee details»

AusCann Group Holdings - Crunchbase Company Profile & Funding

AusCann Group Holdings closed its last funding round on Jul 5, 2018 from a Post-IPO Equity round. Who are AusCann Group Holdings 's competitors? Alternatives and possible โ€ฆSee details»

AusCann Company Profile | Management and Employees List

AusCann is an Australian-based pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines within Australia and โ€ฆSee details»

AusCann โ€“ Medicinal Cannabis Industry Australia - mcia.org.au

AusCann is an Australian company focused on the development and commercialisation of cannabinoid-derived therapeutic products to address unmet needs for humans and animals โ€ฆSee details»

AusCann Group Holdings Ltd - AnnualReports.com

AusCann is an Australian-based company focused on the development and commercialisation of cannabinoid-derived therapeutic products to address unmet needs for humans and animals โ€ฆSee details»

AusCann | ASX-Listed, Medical Cannabis | Cannaus

AusCann is a pharmaceutical company based in Australia โ€“ they specialize in the development, production and distribution of cannabinoid-based medicine within Australia and internationally. They offer a rigorous pharmaceutical โ€ฆSee details»

AUSCANN OPERATIONS PTY LTD - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for AUSCANN OPERATIONS PTY LTD of WANGARA, WESTERN AUSTRALIA. Get the latest business โ€ฆSee details»

AusCann - Overview, News & Competitors | ZoomInfo.com

AusCann contact info: Phone number: +61 863050705 Website: www.auscann.com.au What does AusCann do? AusCann is an Australian-based pharmaceutical company focused on the โ€ฆSee details»

Business Model Analysis of AusCann Holdings Ltd. Report - Desklib

Organization may face the risks related to agriculture as there may be issues related to plant diseases, insects, storm, fire, flood, frost, drought, bird damage, pests, water salinity etc. โ€ฆSee details»

AusCann Company Profile - Office Locations, Competitors ... - Craft

AusCann is a pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines. ... Status Active Founded 2013 HQ Wangara, AU | view all โ€ฆSee details»

FAQ | AusCann

The AusCann share register is managed by Computershare Investor Services Pty Ltd (Computershare). Computershare provides a number of services which can be accessed โ€ฆSee details»

AusCann divests 52 per cent of CannPal for $1 - Business News โ€ฆ

Mar 10, 2023 AusCann indicates this could be through debt, equity, a combination of both, or through marketing, commercialisation and co-development agreements. The group expects โ€ฆSee details»

Argent BioPharma and AusCann enter heads of agreement for โ€ฆ

3 days ago It allows AusCann to enhance its programs with Argentโ€™s regulatory and clinical frameworks. Both companies will also gain access to Neuvis, AusCannโ€™s proprietary self โ€ฆSee details»

CannPal's privatisation pays off with major US partnership

Nov 21, 2024 CannPal, which listed on the ASX in 2017, was acquired by fellow Australian medicinal cannabis company AusCann in a scrip-based deal worth $17.5 million in 2021, with โ€ฆSee details»

AusCann cannabinoid medicines one step closer to market

Aug 16, 2018 AusCann has also earmarked the funds for several key developments including clinical studies, expansion of manufacturing facilities, establishment of a new facility in Chile โ€ฆSee details»

AUSCANN GROUP HOLDINGS LTD ACN 008 095 207 (COMPANY)

On the Corporate Governance page on the Companyโ€™s website at www.auscann.com.au. This Statement sets out corporate governance practices adopted by the Board and which were in โ€ฆSee details»

Argent and AusCann enter strategic partnership | The Australian

Argent BioPharma and AusCann Group have joined forces with a new strategic agreement to advance cannabinoid-based pharmaceutical development by sharing proprietary data and โ€ฆSee details»

Letter to Shareholders - AusCann

AusCann Group Holdings Ltd ACN 008 095 207 (ASX:AC8) Registered address: Level 5, 35 Havelock Street, West Perth WA 6005 Mailing address: PO Box 1746, Wangara WA 6947 T: โ€ฆSee details»

linkstock.net © 2022. All rights reserved